35 Recruiting Trials

Clinical Trials
for Depression in Illinois

35 clinical trials for Depression are currently recruiting participants at study sites in Illinois. Study-related care is provided at no cost.

35
Recruiting trials
81
Study sites
48
Cities
14
Industry-sponsored
7
Phase 2
8
Phase 3

Depression clinical trials in Illinois: what to expect

Depression trials cover new medicines, brain stimulation, talk therapy and digital programs. The busiest area is treatment-resistant depression: studies for people whose current antidepressant has not helped enough, testing rapid-acting medicines, add-on treatments and devices such as transcranial magnetic stimulation. Others compare types of therapy, test app-based programs, or study depression alongside another condition such as chronic pain or heart disease.

In Illinois, recruiting depression studies are concentrated in Chicago, Naperville, Orland Park and Skokie, with sites in 44 other cities. 14 of the 35 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who depression trials usually look for

Most adult trials require a diagnosis of major depressive disorder, a current episode with symptoms above a threshold on a standard questionnaire, and ages 18 to 65. Treatment-resistant trials ask that one or two antidepressants at a proper dose have not worked in the current episode. Common exclusions are bipolar disorder, psychosis, a substance use disorder in the last year and, for safety, a high current suicide risk. Many trials let you continue stable talk therapy.

Some medicine trials add the study drug to the antidepressant you take; others require a supervised taper first. The listing says which.

What taking part involves

Screening is a structured interview with a clinician plus blood work. Medicine trials usually run six to twelve weeks with weekly or fortnightly visits and mood questionnaires, and many include a placebo arm, with close safety monitoring either way; an open-label extension often follows so everyone can receive the active drug. Therapy and app trials run eight to sixteen weeks and compare against usual care. Treatment, visits and tests are free, and most trials pay for time.

Questions worth asking the study team

Whether you would taper your current medicine and how that is supervised; the chance of placebo and whether there is an open-label extension; what happens if you feel worse during the study; and whether your own doctor is kept informed. Research records are kept separate from your medical record unless you ask otherwise.

Showing 20 of 35 recruiting Depression trials in Illinois

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
PHASE2 Chicago, Illinois NCT06591091
This trial is looking for older adults with depression to see if taking clemastine can improve brain function and enhance the effects of antidepressants. Participants will undergo assessments to confirm eligibility before joining the study.
Recruiting
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression
PHASE2 Chicago, Illinois +1 sites NCT06408246
This trial is looking for people with depression to understand how a medication called guanfacine affects brain function and thinking skills. Participants will need to complete some assessments and take the medication for the duration of the study.
Recruiting
Community-based Approach to Lowering Stress Through Mindfulness
NA Chicago, Illinois NCT06987799
This trial is looking for African American adults with high blood pressure and depression. Participants will join an 8-week mindfulness program to help manage stress and improve their symptoms.
Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
PHASE3 Dothan, Alabama +4 sites NCT06372964
This trial is looking for young people aged 10 to 17 who have bipolar depression. Participants will receive either the study medication or a placebo while their mood is monitored.
Recruiting
Brexanolone Lifting Outcomes Of Moms
PHASE3 Tucson, Arizona +4 sites NCT07822321
This trial is looking for women aged 15 to 45 who are experiencing severe postpartum depression. Participants will take the study drug LPCN 1154A to see if it helps reduce their depressive symptoms and to learn about any side effects.
Recruiting
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
PHASE2 Tucson, Arizona +4 sites NCT06524830
This trial is looking for adults with treatment resistant depression. Participants will receive either a new treatment called VLS-01 Buccal Film or a placebo to see how effective it is.
Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
NA Birmingham, Alabama +4 sites NCT03887715
This trial is looking for adults with treatment-resistant depression. Participants will receive either active VNS therapy or a control without stimulation to see how it affects their depression over 12 months.
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
NA Birmingham, Alabama +4 sites NCT06423430
This trial is looking for adults with treatment resistant depression who have not improved with other treatments. Participants will receive a new type of brain stimulation as part of their care.
Recruiting
Maternal Mindfulness: Depression and Postpartum Pain
NA Champaign, Illinois NCT05400382
This trial is looking for women who are expecting to have a cesarean delivery. Participants will use a mobile mindfulness program to help with pain and reduce the risk of depression after childbirth.
Recruiting
Parents and Babies Pilot
NA Chicago, Illinois NCT07607613
This trial is looking for LGBTQ+ individuals who are pregnant or have recently given birth and are experiencing mild depressive symptoms. Participants will help test a program aimed at preventing perinatal depression and share their experiences with it.
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
PHASE3 Bentonville, Arkansas +4 sites NCT04777357
This trial is looking for young people aged 10 to 17 who have bipolar I disorder and are experiencing depressive episodes. Participants will receive either a study drug called cariprazine or a placebo to see how it affects their mood.
Recruiting
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
NA Chicago, Illinois +2 sites NCT06526078
This trial is looking for adults aged 18 to 80 who are being treated with ketamine for depression. Participants will receive additional computer-based cognitive training to see if it helps improve their treatment outcomes.
Recruiting
Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families
NA Chicago, Illinois NCT06261463
This trial is looking for refugee families living in Chicago for less than three years. Participants will join a group intervention aimed at improving family support and mental health.
Recruiting
Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms
NA Chicago, Illinois NCT07485036
This trial is looking for new mothers who are dealing with depression and alcohol use after giving birth. Participants will attend remote therapy sessions and complete surveys to help study if a specific intervention can be helpful.
Recruiting
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
NA Chicago, Illinois NCT07073521
This trial is looking for adults dealing with vision loss who want to improve their adjustment to this change. Participants will join focus groups and therapy sessions to share their experiences and receive support.
Recruiting
Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older
NA Chicago, Illinois +1 sites NCT06636058
This trial is looking for adults aged 50 to 74 who have both depression and obesity. Participants will use digital programs to help manage their weight and depression over a 12-month period.
Recruiting
Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression
NA Chicago, Illinois NCT07610655
This trial is looking for adults who are having lumbar surgery. Participants will receive a noninvasive treatment to see if it helps with recovery in the hospital and reduces symptoms like delirium and depression after their surgery.
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
PHASE3 Tucson, Arizona +4 sites NCT07172516
This trial is looking for adults aged 18 to 74 who are currently experiencing a depressive episode connected to bipolar disorder. Participants will receive either azetukalner or a placebo to see how well it works and its safety.
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
PHASE3 Tucson, Arizona +4 sites NCT07484217
This trial is looking for adults with major depressive disorder and excessive daytime sleepiness symptoms. Participants will first take solriamfetol openly, followed by a period where neither the participant nor the doctor knows if the treatment is the drug or a placebo.
Recruiting
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
PHASE3 Skokie, Illinois +4 sites NCT07716098
This trial is looking for adults with treatment-resistant depression. Participants will compare two doses of esketamine nasal spray with a placebo to see how well it improves their symptoms.
Recruiting

Where the Depression studies are in Illinois

  • Northwestern University, Chicago5 trials
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago3 trials
  • University of Illinois at Chicago, Chicago3 trials
  • Rush University Medical Center, Chicago2 trials
  • Southern Illinois University School of Medicine, Springfield2 trials
  • University of Chicago, Chicago2 trials

Counts are recruiting studies listing at least one site in Illinois, from ClinicalTrials.gov, refreshed every two days.

Depression clinical trials in Illinois: common questions

How many Depression clinical trials are recruiting in Illinois?
TrialFinder currently lists 35 recruiting Depression clinical trials with study sites in Illinois. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Depression clinical trials located in Illinois?
Study sites for the Depression trials listed on this page include Chicago, Champaign, Skokie. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Depression clinical trial in Illinois?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Depression trials in Illinois also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Depression clinical trial in Illinois?
Each study sets its own criteria based on age, Depression diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I have to stop my antidepressant to join a depression trial?
Not always. Many trials add the study treatment to the antidepressant you already take; others ask for a supervised taper before starting. Each listing states which, and the study doctor manages any change.
Is there a placebo in depression trials?
Most medicine trials include a placebo arm, often with two active participants for every one on placebo, and usually followed by an extension where everyone receives the drug. Therapy, device and app trials generally compare against usual care instead.
Can I join if I am already seeing a therapist?
Usually yes for medicine trials, provided the therapy has been ongoing and stable. Trials of a specific therapy may ask you not to start a second one during the study.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Depression trials near you in Illinois.

Get Matched — Free
No insurance required

Depression trials investigate antidepressant medications, TMS, ketamine infusions, psychotherapy protocols, and digital mental-health interventions.

All Depression trials →